金城医药

- 300233

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
金城医药(300233) 利润表
单位:万元
报表日期2023-12-312023-09-302023-06-302023-03-312022-12-31
一、营业总收入353,831.25256,875.27170,529.3382,952.65350,571.70
营业收入353,831.25256,875.27170,529.3382,952.65350,571.70
二、营业总成本329,366.78238,674.95157,048.3376,519.99313,344.92
营业成本199,112.71148,123.7496,972.1047,542.33188,525.57
营业税金及附加3,615.522,809.721,830.52906.173,305.05
销售费用68,064.7648,983.9831,556.5715,031.2162,859.17
管理费用39,075.0825,645.9518,425.309,393.5240,074.31
财务费用1,027.86929.25643.42796.521,470.46
研发费用18,470.8512,182.327,620.422,850.2417,110.35
资产减值损失----------
公允价值变动收益-8.15-1.34-26.45-33.47-48.36
投资收益59.01-7.04-33.31-1.64344.42
其中:对联营企业和合营企业的投资收益-73.05-24.38-15.69-24.58-47.12
汇兑收益----------
三、营业利润22,584.9217,551.6313,417.426,874.7635,377.73
加:营业外收入98.4077.3572.6065.40565.77
减:营业外支出142.56-1.15-79.22-83.511,346.90
其中:非流动资产处置损失----------
四、利润总额22,540.7517,630.1413,569.247,023.6734,596.60
减:所得税费用3,209.652,964.642,491.981,535.716,009.18
五、净利润19,331.1014,665.5011,077.265,487.9728,587.42
归属于母公司所有者的净利润17,470.9413,248.0410,170.945,015.4727,336.46
少数股东损益1,860.161,417.47906.31472.501,250.96
六、每股收益
基本每股收益(元/股)0.45000.34000.26000.13000.7100
稀释每股收益(元/股)0.45000.34000.26000.13000.7100
七、其他综合收益170.52705.67705.67551.12--
八、综合收益总额19,501.6215,371.1711,782.926,039.0928,587.42
归属于母公司所有者的综合收益总额17,641.4613,953.7010,876.615,566.5927,336.46
归属于少数股东的综合收益总额1,860.161,417.47906.31472.501,250.96
下载全部历史数据到excel中 返回页顶